Invention Grant
- Patent Title: Humanized antibodies to LIV-1 and use of same to treat cancer
-
Application No.: US14948183Application Date: 2015-11-20
-
Publication No.: US09783608B2Publication Date: 2017-10-10
- Inventor: Maria Leia Smith , Django Sussman , William Arthur , Albina Nesterova
- Applicant: SEATTLE GENETICS, INC.
- Applicant Address: US WA Bothell
- Assignee: SEATTLE GENETICS, INC.
- Current Assignee: SEATTLE GENETICS, INC.
- Current Assignee Address: US WA Bothell
- Agency: Alston & Bird LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; C07K16/30 ; A61K47/48 ; C07K16/46 ; A61K39/00
Abstract:
The invention provides humanized antibodies that specifically bind to LIV-1. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting LIV-1.
Public/Granted literature
- US20160185858A1 Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer Public/Granted day:2016-06-30
Information query
